Concordance of breast cancer biomarker testing in core needle biopsy and surgical specimens: A single institution experience.

Jessica A Slostad Nicole K YunAimee E SchadSurbhi WarriorLouis F FoggRuta Rao

Published in: Cancer medicine (2022)

Overall, retesting ER and HER2 was more clinically beneficial than retesting PR. To aid decision-making and minimize healthcare costs, we propose patient-centered guidelines on retesting biomarker profiles.

Keyphrases

healthcare
ultrasound guided
decision making
fine needle aspiration
clinical practice
estrogen receptor
endoplasmic reticulum
breast cancer cells
young adults
childhood cancer